Jury Hits J&J with $35M Verdict in Transvaginal Mesh Case

Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

judge holding gavel

An Indiana jury this month awarded $35 million to a woman in a transvaginal mesh case. The jury found Johnson & Johnson and its subsidiary Ethicon negligent in the design and marketing of the Prolift transvaginal mesh device.

Barbara Kaiser and her husband filed a lawsuit against J&J and Ethicon after Kaiser received a Prolift mesh implant during prolapse repair surgery.

Kaiser suffered severe pelvic pain, among other “severe and irreversible injuries,” according to her 2012 complaint.
On March 8, 2018, the Indiana jury ruled in favor of Kaiser and her husband after a nine-day trial.

“Ethicon defended an indefensible product, and the jury stood up for Barbara Kaiser,” Kaiser’s attorney Thomas Plouff told Scotland’s Sunday Post. “They were asked to send a message to Ethicon to deter future wrongdoing, and they did.”

Injured by complications related to Transvaginal Mesh? Get a Free Case Review

The jury awarded the Kaisers $10 million for pain, suffering and monetary damages. Jurors also awarded the couple $25 million in punitive damages for wanton disregard of Kaiser’s safety.

J&J and Ethicon knew the device had a high risk of complications and failure, Kaiser said in her lawsuit. But, the device maker failed to warn the public of the risks.

Kaiser’s surgeon testified that he was unaware of the Prolift’s safety risks.

J&J spokeswoman Mindy Tinsley told MassDevice.com that the company intends to appeal.

“All surgeries to treat pelvic organ prolapse have risks. While we empathize with those who have experienced complications, many women with pelvic mesh see an improvement in their day-to-day lives,” Tinsley told MassDevice.com via email. “Ethicon stands by, and will continue to defend, our pelvic mesh products in litigation.”

This verdict comes two days after J&J lost its bid to overturn a $15 million verdict for Elizabeth Hyrmoc. Hyrmoc’s trial took place in November 2017 in New Jersey.

J&J and Ethicon still faced more than 13,600 mesh lawsuits as of Feb. 15, 2018.

  •  
  •  
  •  

Did you find Drugwatch helpful?

2 Cited Research Articles

  1. Perriello, B. (2018, March 12). Johnson & Johnson’s Ethicon loses $35M pelvic mesh lawsuit. Retrieved from https://www.massdevice.com/johnson-johnsons-ethicon-loses-35m-pelvic-mesh-lawsuit/
  2. Scott, M. (2018, March 11). US jury awards mesh victim almost £30m over ‘unreasonably dangerous’ implant which has been used in Scotland. Retrieved from https://www.sundaypost.com/fp/us-jury-awards-mesh-victim-almost-30m-in-damages-over-unreasonably-dangerous-implant-which-has-been-used-in-scotland/
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(844) 480-1538

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.

Live Chat Icon livechat loading spinner